Popular Media (Affiliate)
Killing drug ads won’t lower prices — it will kill innovation
Blaze media
View Original Source
The United States is one of the few countries that allows prescription drugmakers to speak directly to patients. That simple fact now fuels political calls to “ban the ads.” But restricting direct-to-consumer advertising would do more than change what runs during football games. It would shrink the flow of information to patients and push our system toward the bureaucratic throttling that has turned other countries into innovation laggards.
Read the full piece here.